This 2001 randomized controlled trial evaluated the effectiveness of intravenous magnesium sulfate in treating acute migraine attacks. Thirty patients were enrolled; those who received 1 g of magnesium over 15 minutes experienced significant improvements—86.6% became pain-free, and 100% reported relief from accompanying symptoms, compared to minimal improvement in the placebo
